Documents & Downloads

Lerodalcibep

Lipid-Lowering Agent

Lerodalcibep is a recombinant fusion protein comprising a PCSK9-binding domain and human serum albumin, functioning as an effective lipid-lowering agent. Its primary mechanism involves the inhibition of PCSK9, leading to enhanced LDL receptor activity and reduced cholesterol levels. This compound is valuable for research focused on hypercholesterolemia and cardiovascular disease management, facilitating studies aimed at understanding lipid metabolism and therapeutic interventions.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
CAS Number	2250073-78-8
Applications	Lipid-Lowering Agent
Synonyms	LIB003

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.